European emergence of ciprofloxacin-resistant Escherichia coli clonal groups O25:H4-ST 131 and O15:K52:H1 causing community-acquired uncomplicated cystitis

被引:125
作者
Cagnacci, Simone [1 ]
Gualco, Laura [1 ]
Debbia, Eugenio [1 ]
Schito, Gian Carlo [1 ]
Marchese, Anna [1 ]
机构
[1] Univ Genoa, Sez Microbiol DiSCAT, I-16132 Genoa, Italy
关键词
D O I
10.1128/JCM.00640-08
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
A total of 148 E. coli strains displaying reduced susceptibility to ciprofloxacin (MIC >= 2 mu g/ml) and causing uncomplicated urinary tract infections in eight European countries during 2003 to 2006 were studied. Their phylogenetic groups, biochemical profiles, and antibiotic susceptibilities were determined. Determination of the O:H serotype, pulsed-field gel electrophoresis (PFGE), randomly amplified polymorphic DNA (RAPD) PCR, and multilocus sequence typing provided additional discrimination. The majority (82.4%) of the microorganisms (122/148) carried resistance to two or more additional drugs, with the pattern ciprofloxacin - trimethoprim-sufamethoxazole - tetracycline - ampicillin being the most represented (73 strains out of 148; 49.3%). Extended-spectrum beta-lactamase production was detected in 12/148 strains (8.1%), with CTX-M-15 being the most-common enzyme. Six strains out of the whole collection studied (4.0%) contained a qnrB-like gene. Overall, 55 different PFGE or RAPD PCR profiles could be distinguished, indicating a substantial heterogeneity. However, about one-third (51/148) of the strains belonged to two clonal groups: O15:K52:H1 (phylogenetic group B2, lactose-nonfermenting variant, ciprofloxacin MIC of 16 mu g/ml) and O25:H4 sequence type 131 (ST-131) (phylogenetic group D, ciprofloxacin MIC of >= 32 mu g/ml). With the exception of Poland, strains of these two groups were isolated in samples from all participating countries but more frequently in samples from Spain and Italy. In some representative strains of the two main clonal groups, alterations in GyrA and ParC were the basic mechanism of fluoroquinolone resistance. In some members of the O25: H4 ST-131 group, displaying a ciprofloxacin MIC of >32 mu g/ml, additional OmpF loss or pump efflux overexpression was found. In the Mediterranean area, strains belonging to these two clonal groups played a major role in determining the high rate of fluoroquinolone-resistant E. coli strains observed in the community.
引用
收藏
页码:2605 / 2612
页数:8
相关论文
共 41 条
  • [1] Linkage of acquired quinolone resistance (qnrS1) and metallo-β-lactamase (blaVIM-1) genes in multiple species of Enterobacteriaceae from Bolzano, Italy
    Aschbacher, Richard
    Doumith, Michel
    Livermore, David M.
    Larcher, Clara
    Woodford, Neil
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 61 (03) : 515 - 523
  • [2] Growing group of extended-spectrum β-lactamases:: The CTX-M enzymes
    Bonnet, R
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (01) : 1 - 14
  • [3] Bloodstream infections caused by multidrug-resistant Klebsiella pneumoniae producing the carbapenem-hydrolysing VIM-1 metallo-β-lactamase:: first Italian outbreak
    Cagnacci, Simone
    Gualco, Laura
    Roveta, Simona
    Mannelli, Stefania
    Borgianni, Luisa
    Docquier, Jean-Denis
    Dodi, Ferdinando
    Centanaro, Monica
    Debbia, Eugenio
    Marchese, Anna
    Rossolini, Gian Maria
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 61 (02) : 296 - 300
  • [4] Multiplex PCR for detection of plasmid-mediated quinolone resistance qnr genes in ESBL-producing enterobacterial isolates
    Cattoir, Vincent
    Poirel, Laurent
    Rotimi, Vincent
    Soussy, Claude-James
    Nordmann, Patrice
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 60 (02) : 394 - 397
  • [5] Rapid and simple determination of the Escherichia coli phylogenetic group
    Clermont, O
    Bonacorsi, S
    Bingen, E
    [J]. APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2000, 66 (10) : 4555 - 4558
  • [6] Clinical and Laboratory Standards Institute, 2006, M2A9 CLSI
  • [7] Clinical and Laboratory Standards Institute, 2006, M7A7 CLSI
  • [8] Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalized patients
    Colodner, R
    Rock, W
    Chazan, B
    Keller, N
    Guy, N
    Sakran, W
    Raz, R
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2004, 23 (03) : 163 - 167
  • [9] Escherichia coli bacteraemia. Serotype O15:K52:H1 as a urinary pathogen
    Dalmau, D
    Navarro, F
    Mirelis, B
    Blanco, J
    Garau, J
    Prats, G
    [J]. JOURNAL OF HOSPITAL INFECTION, 1996, 34 (03) : 233 - 234
  • [10] Antimicrobial susceptibility patterns of contemporary pathogens from uncomplicated urinary tract infections isolated in a multicenter Italian survey: Possible impact on guidelines
    Fadda, G
    Nicoletti, G
    Schito, GC
    Tempera, G
    [J]. JOURNAL OF CHEMOTHERAPY, 2005, 17 (03) : 251 - 257